4//SEC Filing
Karunatilake Chulani 4
Accession 0000950170-25-002342
CIK 0001785530other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:43 PM ET
Size
7.5 KB
Accession
0000950170-25-002342
Insider Transaction Report
Form 4
Karunatilake Chulani
Chief Technology Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-02+153,129→ 153,129 totalExercise: $1.56From: 2027-01-02Exp: 2034-12-31→ Common Stock (153,129 underlying) - Award
Stock Option (right to buy)
2025-01-02+150,000→ 150,000 totalExercise: $1.56Exp: 2034-12-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The option was granted on January 2, 2025 with a Vesting Commencement Date of January 1, 2025. The shares underlying the option vest in equal monthly installments over four years, with the initial vesting to commence on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2029.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001867326
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:43 PM ET
- Size
- 7.5 KB